Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: HER-2 Positive Metastatic Breast Cancer
Interventions: DRUG: Etoposide|DRUG: Trastuzumab
Sponsor: Medstar Health Research Institute
Collaborators: Genentech, Inc.